Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for Macula-off Retinal Detachment
NCT02068625Phase 4Terminated
- Sponsor
- Insel Gruppe
- Start
- Sep 2010
- Primary completion
- Dec 2018
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of rasagiline in rhegmatogenous retinal detachment (RRD), sponsored by Insel Gruppe. Started Sep 2010; status: terminated.
02
Drugs
rasagiline
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on NCT02068625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068625.